| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 244,282 | 41,157 | 64,834 | 98,253 |
| Short-term marketable securities | 120,445 | 187,640 | 187,099 | 183,126 |
| Accounts receivable | 4,674 | 4,638 | 29,352 | 2,631 |
| Prepaid expenses and other current assets | 16,279 | 15,332 | 10,427 | 12,120 |
| Total current assets | 385,680 | 248,767 | 291,712 | 296,130 |
| Long-term marketable securities | 39,116 | 41,787 | 47,427 | 51,996 |
| Long-term prepaids and other assets | 6,652 | 6,674 | 7,388 | 8,855 |
| Deferred tax asset | 4,707 | 4,707 | 4,862 | 4,769 |
| Property and equipment, net | 14,854 | 15,502 | 15,819 | 16,314 |
| Operating lease right-of-use assets | 14,016 | 15,724 | 16,648 | 16,260 |
| Intangible assets, net | 1,174 | 1,350 | 1,397 | 2,045 |
| Goodwill | 12,016 | 12,016 | 12,016 | 12,016 |
| Total assets | 478,215 | 346,527 | 397,269 | 408,385 |
| Accounts payable and accrued liabilities | 30,226 | 36,346 | 34,430 | 31,003 |
| Income tax payable | 66 | 83 | 1,016 | 102 |
| Current portion of operating lease liability | 3,279 | 3,471 | 3,400 | 3,586 |
| Deferred revenue | 2,078 | 2,418 | 3,197 | 3,811 |
| Total current liabilities | 35,649 | 42,318 | 42,043 | 38,502 |
| Long-term portion of operating lease liability | 13,763 | 14,796 | 15,504 | 15,092 |
| Deferred revenue | 14,606 | 14,606 | 14,607 | 14,607 |
| Liability related to sale of future royalties | 246,503 | NaN | NaN | NaN |
| Other long-term liabilities | 278 | 278 | 278 | 828 |
| Deferred tax liability | 3,827 | 6,028 | 4,773 | 4,850 |
| Total liabilities | 314,626 | 78,026 | 77,205 | 73,879 |
| Common stock, 0.00001 par value 900,000,000 authorized shares at march31, 2026 and december31, 2025, respectively 73,102,689 and 74,638,413 shares issued and outstanding at march31, 2026 and december31, 2025, respectively | 1,128,553 | 1,105,176 | 1,092,929 | 1,074,079 |
| Exchangeable shares, no par value, 550,884 and 553,184 issued and outstanding shares at march31, 2026 and december31, 2025, respectively | 7,905 | 7,938 | 8,168 | 8,178 |
| Additional paid-in capital | 107,530 | 114,626 | 111,489 | 109,243 |
| Accumulated other comprehensive loss | -6,565 | -6,079 | -6,050 | -6,340 |
| Accumulated deficit | -1,073,834 | -953,160 | -886,472 | -850,654 |
| Total stockholders equity | 163,589 | 268,501 | 320,064 | 334,506 |
| Total liabilities and stockholders equity | 478,215 | 346,527 | 397,269 | 408,385 |
Zymeworks Inc. (ZYME)
Zymeworks Inc. (ZYME)